Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan

Title
Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan
Authors
Keywords
Bisphosphonate, Risedronate, Metabolic syndrome, Life style-related disease, Bone mineral density, Bone turnover markers
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 98, Issue 2, Pages 114-122
Publisher
Springer Nature
Online
2015-10-14
DOI
10.1007/s00223-015-0071-9

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started